Portfolio Analysis November 2020
United States pharma giant Pfizer Inc and its German partner BioNTech announced recently that final results from the phase three trial of their COVID-19 vaccine showed it to be 95 percent effective – the highest success rate for any pandemic candidate in late-stage trials so far. The firms submitted an application with the US FDA … Read more